Results 131 to 140 of about 1,265 (198)

Model systems of human immunodef iciency virus (HIV-1) for in vitro eff icacy assessment of candidate vaccines and drugs against HIV-1. [PDF]

open access: yesVavilovskii Zhurnal Genet Selektsii, 2022
Rudometova NB   +4 more
europepmc   +1 more source

A retrospective analysis of oral cholera vaccine use, disease severity and deaths during an outbreak in South Sudan. [PDF]

open access: yesBull World Health Organ, 2016
Bekolo CE   +5 more
europepmc   +1 more source

Increased immunization coverage addresses the equity gap in Nepal. [PDF]

open access: yesBull World Health Organ, 2017
Kc A   +5 more
europepmc   +1 more source

Dengue vaccine: local decisions, global consequences. [PDF]

open access: yesBull World Health Organ, 2016
López-Gatell H   +3 more
europepmc   +1 more source

Estimation of child vaccination coverage at state and national levels in India. [PDF]

open access: yesBull World Health Organ, 2016
Bhatnagar P   +5 more
europepmc   +1 more source

Economic benefits of keeping vaccines at ambient temperature during mass vaccination: the case of meningitis A vaccine in Chad. [PDF]

open access: yesBull World Health Organ, 2014
Lydon P   +6 more
europepmc   +1 more source

Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa. [PDF]

open access: yesBull World Health Organ, 2014
Groome MJ   +8 more
europepmc   +1 more source

Oral cholera vaccine in cholera prevention and control, Malawi. [PDF]

open access: yesBull World Health Organ, 2018
M'bangombe M   +16 more
europepmc   +1 more source

Pneumococcal conjugate vaccines and hospitalization of children for pneumonia: a time-series analysis, South Africa, 2006-2014. [PDF]

open access: yesBull World Health Organ, 2017
Izu A   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy